Conference Paper: Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients

File Download Links for fulltext
(May Require Subscription)
  • Find via
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleOptimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients
AuthorsZeuzem, S
Lai, CL
Gane, E
Liaw, YF
Thongsawat, S
Wang, YM
Chen, Y
Heathcote, J
Rasenack, J
Bzowej, N
Naoumov, N
Chao, G
Fielman, B
Brown, N
Issue Date2006
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
CitationJournal of Hepatology, v. 44 n. Suppl 2, p. S24 [How to Cite?]
ISSN0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
DC Field
Value
dc.contributor.authorZeuzem, S
dc.contributor.authorLai, CL
dc.contributor.authorGane, E
dc.contributor.authorLiaw, YF
dc.contributor.authorThongsawat, S
dc.contributor.authorWang, YM
dc.contributor.authorChen, Y
dc.contributor.authorHeathcote, J
dc.contributor.authorRasenack, J
dc.contributor.authorBzowej, N
dc.contributor.authorNaoumov, N
dc.contributor.authorChao, G
dc.contributor.authorFielman, B
dc.contributor.authorBrown, N
dc.date.accessioned2010-09-25T19:48:34Z
dc.date.available2010-09-25T19:48:34Z
dc.date.issued2006
dc.identifier.citationJournal of Hepatology, v. 44 n. Suppl 2, p. S24 [How to Cite?]
dc.identifier.hkuros122307
dc.identifier.issn0168-8278
2011 Impact Factor: 9.264
2011 SCImago Journal Rankings: 0.765
dc.identifier.issueSuppl 2
dc.identifier.openurl
dc.identifier.spage24
dc.identifier.urihttp://hdl.handle.net/10722/101411
dc.identifier.volume, v. 44 n. Suppl 2
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
dc.relation.ispartofJournal of Hepatology
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
dc.titleOptimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients
dc.typeConference_Paper